Hypometric Genetics: Improved Power in Genetic Discovery by Incorporating Quality Control Flags

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 2024 Oct 23

PMID 39442521

Authors

Yosuke Tanigawa

Manolis Kellis

Affiliations

Soon will be listed here.

Abstract

Balancing the tradeoff between quantity and quality of phenotypic data is critical in omics studies. Measurements below the limit of quantification (BLQ) are often tagged in quality control fields, but these flags are currently underutilized in human genetics studies. Extreme phenotype sampling is advantageous for mapping rare variant effects. We hypothesize that genetic drivers, along with environmental and technical factors, contribute to the presence of BLQ flags. Here, we introduce "hypometric genetics" (hMG) analysis and uncover a genetic basis for BLQ flags, indicating an additional source of genetic signal for genetic discovery, especially from phenotypic extremes. Applying our hMG approach to n = 227,469 UK Biobank individuals with metabolomic profiles, we reveal more than 5% heritability for BLQ flags and report biologically relevant associations, for example, at APOC3, APOA5, and PDE3B loci. For common variants, polygenic scores trained only for BLQ flags predict the corresponding quantitative traits with 91% accuracy, validating the genetic basis. For rare coding variant associations, we find an asymmetric 65.4% higher enrichment of metabolite-lowering associations for BLQ flags, highlighting the impact of putative loss-of-function variants with large effects on phenotypic extremes. Joint analysis of binarized BLQ flags and the corresponding quantitative metabolite measurements improves power in Bayesian rare variant aggregation tests, resulting in an average of 181% more prioritized genes. Our approach is broadly applicable to omics profiling. Overall, our results underscore the benefit of integrating quality control flags and quantitative measurements and highlight the advantage of joint analysis of population-based samples and phenotypic extremes in human genetics studies.

References

Tahir U, Katz D, Avila-Pachecho J, Bick A, Pampana A, Robbins J . Whole Genome Association Study of the Plasma Metabolome Identifies Metabolites Linked to Cardiometabolic Disease in Black Individuals. Nat Commun. 2022; 13(1):4923. PMC: 9395431. DOI: 10.1038/s41467-022-32275-3. View

Allen N, Lacey B, Lawlor D, Pell J, Gallacher J, Smeeth L . Prospective study design and data analysis in UK Biobank. Sci Transl Med. 2024; 16(729):eadf4428. PMC: 11127744. DOI: 10.1126/scitranslmed.adf4428. View

Karczewski K, Francioli L, Tiao G, Cummings B, Alfoldi J, Wang Q . The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020; 581(7809):434-443. PMC: 7334197. DOI: 10.1038/s41586-020-2308-7. View

Dhindsa R, Burren O, Sun B, Prins B, Matelska D, Wheeler E . Rare variant associations with plasma protein levels in the UK Biobank. Nature. 2023; 622(7982):339-347. PMC: 10567546. DOI: 10.1038/s41586-023-06547-x. View

Tanigawa Y, Wainberg M, Karjalainen J, Kiiskinen T, Venkataraman G, Lemmela S . Rare protein-altering variants in ANGPTL7 lower intraocular pressure and protect against glaucoma. PLoS Genet. 2020; 16(5):e1008682. PMC: 7199928. DOI: 10.1371/journal.pgen.1008682. View

Peloso G, Rader D, Gabriel S, Kathiresan S, Daly M, Neale B . Phenotypic extremes in rare variant study designs. Eur J Hum Genet. 2015; 24(6):924-30. PMC: 4867440. DOI: 10.1038/ejhg.2015.197. View

Lee S, Abecasis G, Boehnke M, Lin X . Rare-variant association analysis: study designs and statistical tests. Am J Hum Genet. 2014; 95(1):5-23. PMC: 4085641. DOI: 10.1016/j.ajhg.2014.06.009. View

DeLong E, Delong D, Clarke-Pearson D . Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44(3):837-45. View

Chung W, Chen J, Turman C, Lindstrom S, Zhu Z, Loh P . Efficient cross-trait penalized regression increases prediction accuracy in large cohorts using secondary phenotypes. Nat Commun. 2019; 10(1):569. PMC: 6361917. DOI: 10.1038/s41467-019-08535-0. View

10.

Hecht M, Veigure R, Couchman L, Barker C, Standing J, Takkis K . Utilization of data below the analytical limit of quantitation in pharmacokinetic analysis and modeling: promoting interdisciplinary debate. Bioanalysis. 2018; 10(15):1229-1248. DOI: 10.4155/bio-2018-0078. View

11.

Chen Y, Lu T, Pettersson-Kymmer U, Stewart I, Butler-Laporte G, Nakanishi T . Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet. 2023; 55(1):44-53. PMC: 7614162. DOI: 10.1038/s41588-022-01270-1. View

12.

Venkataraman G, DeBoever C, Tanigawa Y, Aguirre M, Ioannidis A, Mostafavi H . Bayesian model comparison for rare-variant association studies. Am J Hum Genet. 2021; 108(12):2354-2367. PMC: 8715195. DOI: 10.1016/j.ajhg.2021.11.005. View

13.

Friedman J, Hastie T, Tibshirani R . Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010; 33(1):1-22. PMC: 2929880. View

14.

Sinnott-Armstrong N, Tanigawa Y, Amar D, Mars N, Benner C, Aguirre M . Genetics of 35 blood and urine biomarkers in the UK Biobank. Nat Genet. 2021; 53(2):185-194. PMC: 7867639. DOI: 10.1038/s41588-020-00757-z. View

15.

Julkunen H, Cichonska A, Tiainen M, Koskela H, Nybo K, Makela V . Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank. Nat Commun. 2023; 14(1):604. PMC: 9898515. DOI: 10.1038/s41467-023-36231-7. View

16.

Karjalainen M, Karthikeyan S, Oliver-Williams C, Sliz E, Allara E, Fung W . Genome-wide characterization of circulating metabolic biomarkers. Nature. 2024; 628(8006):130-138. PMC: 10990933. DOI: 10.1038/s41586-024-07148-y. View

17.

Bergstrand M, Karlsson M . Handling data below the limit of quantification in mixed effect models. AAPS J. 2009; 11(2):371-80. PMC: 2691472. DOI: 10.1208/s12248-009-9112-5. View

18.

Sun B, Chiou J, Traylor M, Benner C, Hsu Y, Richardson T . Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023; 622(7982):329-338. PMC: 10567551. DOI: 10.1038/s41586-023-06592-6. View

19.

Qian J, Tanigawa Y, Li R, Tibshirani R, Rivas M, Hastie T . LARGE-SCALE MULTIVARIATE SPARSE REGRESSION WITH APPLICATIONS TO UK BIOBANK. Ann Appl Stat. 2022; 16(3):1891-1918. PMC: 9454085. DOI: 10.1214/21-aoas1575. View

20.

McLaren W, Gil L, Hunt S, Riat H, Ritchie G, Thormann A . The Ensembl Variant Effect Predictor. Genome Biol. 2016; 17(1):122. PMC: 4893825. DOI: 10.1186/s13059-016-0974-4. View